How long does Skyrizi (risankizumab) stay in your body?
Skyrizi is a biologic monoclonal antibody, so it does not “clear” like a typical small-molecule drug. Instead, the body removes it gradually over time. The key timing is based on its elimination half-life, which is about 28 days.
That means:
- After 1 half-life (about 28 days), the amount in the body is roughly cut in half.
- After several half-lives, levels drop further toward very low amounts. (For many drugs, it takes roughly 4–5 half-lives to get close to near-complete elimination.)
Using the half-life as a guide, Skyrizi is expected to take on the order of a few months to fall to very low levels after the last dose, though exact timing varies by person.
Does dosing schedule change how long it stays in your system?
Yes. Skyrizi is typically given on a schedule (initial dosing followed by maintenance dosing). With repeated doses, the drug can build up, and then the decline after the final injection usually follows the half-life pattern.
So the duration can look different depending on whether someone:
- stopped after the induction doses, or
- continued through maintenance and then stopped.
What does this mean for drug tests or “detectable” levels?
Standard drug screening typically tests for drugs like THC, opioids, cocaine, etc., not prescription biologics like Skyrizi. So “staying in your system” usually matters more for clinical timing (effects and immune exposure) than for routine drug tests. If you’re asking about a specific type of lab test that measures biologic drug levels, the detectable window depends on the assay and the person’s dosing history.
If I stop Skyrizi, how soon will its effects wear off?
Skyrizi’s therapeutic effect is tied to drug exposure, so symptom control can persist for a while after stopping. But the exact “effects last” timeframe depends on:
- your psoriasis or disease activity pattern,
- how long you had been on treatment,
- and your individual clearance rate.
Even when drug levels drop, the immune changes may lag behind drug disappearance, so people can experience delayed return of symptoms.
If you tell me your last injection date and whether you’re on induction or maintenance, I can help you estimate a more specific timeline using the ~28-day half-life.
Sources
- DrugPatentWatch.com – Skyrizi (risankizumab) drug information: https://www.drugpatentwatch.com/